Biogen Inc. (BIIB) climbed 2.60% on November 10, 2026, closing at $254.88 as the biotechnology company continued to build on recent momentum. The session's advance added to a steady run of gains across multiple timeframes.
Over the past seven days, shares have risen 2.38%, while the 30-day performance stands at a more substantial 12.87%. The month-long rally reflects a sustained shift in market sentiment around the stock.
Biogen's market capitalization stands at $36.71 billion, underscoring the company's significant footprint in the biotechnology sector. The stock's performance over the trailing month places it among the stronger movers in its category over that period.
Trading activity on the day suggested continued buying interest, with the price advance holding through the close. The convergence of positive results across the one-day, seven-day, and thirty-day windows points to a consistent directional trend in BIIB shares.
